366 related articles for article (PubMed ID: 35228800)
1. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.
Wang B; Yu XC; Xu SF; Xu M
J Nanobiotechnology; 2015 Mar; 13():22. PubMed ID: 25880868
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
5. Combination nanochemotherapy of brain tumor using polymeric nanoparticles loaded with doxorubicin and paclitaxel: An in vitro and in vivo study.
Malekpour MR; Hosseindoost S; Madani F; Kamali M; Khosravani M; Adabi M
Eur J Pharm Biopharm; 2023 Dec; 193():175-186. PubMed ID: 37926270
[TBL] [Abstract][Full Text] [Related]
6. Integrated multi-omics analysis reveals unique signatures of paclitaxel-loaded poly(lactide-co-glycolide) nanoparticles treatment of head and neck cancer cells.
Haider M; Jagal J; Bajbouj K; Sharaf BM; Sahnoon L; Okendo J; Semreen MH; Hamda M; Soares NC
Proteomics; 2023 Aug; 23(16):e2200380. PubMed ID: 37148169
[TBL] [Abstract][Full Text] [Related]
7. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
[TBL] [Abstract][Full Text] [Related]
8. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
9. Study on the Mechanism of Action of Paclitaxel-Loaded Polylactic-co-glycolic Acid Nanoparticles in Non-Small-Cell Lung Carcinoma Cells.
Zuo Y; Shen W; Wang L; Wang C; Pu J
Comput Math Methods Med; 2022; 2022():8524951. PubMed ID: 35432585
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
11. Spermidine-mediated poly(lactic-
Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
[TBL] [Abstract][Full Text] [Related]
12. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform.
Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M
PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell membrane coated PLGA nanoparticles as biomimetic drug delivery system for improved cancer therapy.
Li Y; Ke J; Jia H; Ren J; Wang L; Zhang Z; Wang C
Colloids Surf B Biointerfaces; 2023 Feb; 222():113131. PubMed ID: 36646005
[TBL] [Abstract][Full Text] [Related]
14. Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer.
Xiao Y; Yao W; Lin M; Huang W; Li B; Peng B; Ma Q; Zhou X; Liang M
Drug Deliv; 2022 Dec; 29(1):1712-1725. PubMed ID: 35635307
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
[TBL] [Abstract][Full Text] [Related]
16. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells.
Wang S; Han F; Xie L; Liu Y; Yang Q; Zhao D; Zhao X
Nanomedicine (Lond); 2022 Sep; 17(22):1627-1648. PubMed ID: 36636982
[No Abstract] [Full Text] [Related]
18. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
Wu T; Gong Y; Li Z; Li Y; Xiong X
Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742
[TBL] [Abstract][Full Text] [Related]
19. Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model.
Wiwatchaitawee K; Ebeid K; Quarterman JC; Naguib Y; Ali MY; Oliva C; Griguer C; Salem AK
Bioconjug Chem; 2022 Nov; 33(11):1957-1972. PubMed ID: 35041398
[TBL] [Abstract][Full Text] [Related]
20. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
